Logo image of CLBT

CELLEBRITE DI LTD (CLBT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CLBT - IL0011794802 - Common Stock

18.11 USD
-0.09 (-0.49%)
Last: 12/5/2025, 11:13:50 AM
Fundamental Rating

6

CLBT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 281 industry peers in the Software industry. Both the health and profitability get an excellent rating, making CLBT a very profitable company, without any liquidiy or solvency issues. CLBT is valied quite expensively at the moment, while it does show a decent growth rate. These ratings could make CLBT a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CLBT was profitable.
CLBT had a positive operating cash flow in the past year.
In multiple years CLBT reported negative net income over the last 5 years.
In the past 5 years CLBT always reported a positive cash flow from operatings.
CLBT Yearly Net Income VS EBIT VS OCF VS FCFCLBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of 9.15%, CLBT belongs to the top of the industry, outperforming 81.14% of the companies in the same industry.
The Return On Equity of CLBT (17.05%) is better than 84.34% of its industry peers.
CLBT has a Return On Invested Capital of 9.38%. This is amongst the best in the industry. CLBT outperforms 83.63% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLBT is below the industry average of 12.03%.
The last Return On Invested Capital (9.38%) for CLBT is above the 3 year average (7.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.15%
ROE 17.05%
ROIC 9.38%
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
CLBT Yearly ROA, ROE, ROICCLBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

Looking at the Profit Margin, with a value of 16.74%, CLBT belongs to the top of the industry, outperforming 80.43% of the companies in the same industry.
The Operating Margin of CLBT (13.47%) is better than 79.00% of its industry peers.
In the last couple of years the Operating Margin of CLBT has grown nicely.
CLBT's Gross Margin of 83.96% is amongst the best of the industry. CLBT outperforms 91.10% of its industry peers.
In the last couple of years the Gross Margin of CLBT has remained more or less at the same level.
Industry RankSector Rank
OM 13.47%
PM (TTM) 16.74%
GM 83.96%
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
CLBT Yearly Profit, Operating, Gross MarginsCLBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CLBT is creating some value.
The number of shares outstanding for CLBT has been increased compared to 1 year ago.
CLBT has more shares outstanding than it did 5 years ago.
CLBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CLBT Yearly Shares OutstandingCLBT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CLBT Yearly Total Debt VS Total AssetsCLBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

CLBT has an Altman-Z score of 8.02. This indicates that CLBT is financially healthy and has little risk of bankruptcy at the moment.
CLBT has a better Altman-Z score (8.02) than 81.49% of its industry peers.
There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.02
ROIC/WACC1.04
WACC9.04%
CLBT Yearly LT Debt VS Equity VS FCFCLBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CLBT has a Current Ratio of 2.11. This indicates that CLBT is financially healthy and has no problem in meeting its short term obligations.
CLBT's Current ratio of 2.11 is fine compared to the rest of the industry. CLBT outperforms 62.63% of its industry peers.
A Quick Ratio of 2.08 indicates that CLBT has no problem at all paying its short term obligations.
CLBT's Quick ratio of 2.08 is fine compared to the rest of the industry. CLBT outperforms 61.92% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 2.08
CLBT Yearly Current Assets VS Current LiabilitesCLBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.98% over the past year.
The Revenue has grown by 18.37% in the past year. This is quite good.
CLBT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.47% yearly.
EPS 1Y (TTM)6.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)18.37%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%17.94%

3.2 Future

CLBT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.94% yearly.
CLBT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.59% yearly.
EPS Next Y18.9%
EPS Next 2Y12.72%
EPS Next 3Y12.96%
EPS Next 5Y12.94%
Revenue Next Year17.63%
Revenue Next 2Y17.21%
Revenue Next 3Y17.04%
Revenue Next 5Y16.59%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CLBT Yearly Revenue VS EstimatesCLBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
CLBT Yearly EPS VS EstimatesCLBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 39.37 indicates a quite expensive valuation of CLBT.
The rest of the industry has a similar Price/Earnings ratio as CLBT.
Compared to an average S&P500 Price/Earnings ratio of 26.41, CLBT is valued a bit more expensive.
CLBT is valuated quite expensively with a Price/Forward Earnings ratio of 33.94.
The rest of the industry has a similar Price/Forward Earnings ratio as CLBT.
CLBT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 35.40, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 39.37
Fwd PE 33.94
CLBT Price Earnings VS Forward Price EarningsCLBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

CLBT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CLBT is cheaper than 62.28% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CLBT is valued a bit cheaper than 68.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 31.83
EV/EBITDA 51.06
CLBT Per share dataCLBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLBT does not grow enough to justify the current Price/Earnings ratio.
CLBT has a very decent profitability rating, which may justify a higher PE ratio.
CLBT's earnings are expected to grow with 12.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.08
PEG (5Y)N/A
EPS Next 2Y12.72%
EPS Next 3Y12.96%

0

5. Dividend

5.1 Amount

CLBT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CELLEBRITE DI LTD

NASDAQ:CLBT (12/5/2025, 11:13:50 AM)

18.11

-0.09 (-0.49%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners44.23%
Inst Owner Change8.59%
Ins Owners2.65%
Ins Owner ChangeN/A
Market Cap4.43B
Revenue(TTM)455.90M
Net Income(TTM)76.33M
Analysts84.29
Price Target25.21 (39.2%)
Short Float %6%
Short Ratio5.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.18%
Min EPS beat(2)9.55%
Max EPS beat(2)12.81%
EPS beat(4)4
Avg EPS beat(4)9.8%
Min EPS beat(4)0.93%
Max EPS beat(4)15.93%
EPS beat(8)8
Avg EPS beat(8)38.68%
EPS beat(12)12
Avg EPS beat(12)58.72%
EPS beat(16)13
Avg EPS beat(16)32.65%
Revenue beat(2)1
Avg Revenue beat(2)0.12%
Min Revenue beat(2)-1.03%
Max Revenue beat(2)1.27%
Revenue beat(4)1
Avg Revenue beat(4)-0.9%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)1.27%
Revenue beat(8)5
Avg Revenue beat(8)1.02%
Revenue beat(12)8
Avg Revenue beat(12)0.86%
Revenue beat(16)9
Avg Revenue beat(16)-0.08%
PT rev (1m)4.43%
PT rev (3m)7.45%
EPS NQ rev (1m)0.95%
EPS NQ rev (3m)-0.11%
EPS NY rev (1m)0%
EPS NY rev (3m)0.88%
Revenue NQ rev (1m)0.48%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.11%
Valuation
Industry RankSector Rank
PE 39.37
Fwd PE 33.94
P/S 9.71
P/FCF 31.83
P/OCF 28.99
P/B 9.89
P/tB 10.82
EV/EBITDA 51.06
EPS(TTM)0.46
EY2.54%
EPS(NY)0.53
Fwd EY2.95%
FCF(TTM)0.57
FCFY3.14%
OCF(TTM)0.62
OCFY3.45%
SpS1.86
BVpS1.83
TBVpS1.67
PEG (NY)2.08
PEG (5Y)N/A
Graham Number4.35
Profitability
Industry RankSector Rank
ROA 9.15%
ROE 17.05%
ROCE 11.87%
ROIC 9.38%
ROICexc N/A
ROICexgc N/A
OM 13.47%
PM (TTM) 16.74%
GM 83.96%
FCFM 30.51%
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.94%
ROCE(5y)9.6%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 127.51%
Cap/Sales 2.98%
Interest Coverage 250
Cash Conversion 211.92%
Profit Quality 182.24%
Current Ratio 2.11
Quick Ratio 2.08
Altman-Z 8.02
F-Score6
WACC9.04%
ROIC/WACC1.04
Cap/Depr(3y)92.67%
Cap/Depr(5y)99.76%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y18.9%
EPS Next 2Y12.72%
EPS Next 3Y12.96%
EPS Next 5Y12.94%
Revenue 1Y (TTM)18.37%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%17.94%
Revenue Next Year17.63%
Revenue Next 2Y17.21%
Revenue Next 3Y17.04%
Revenue Next 5Y16.59%
EBIT growth 1Y9.3%
EBIT growth 3Y30.51%
EBIT growth 5YN/A
EBIT Next Year32.85%
EBIT Next 3Y23.1%
EBIT Next 5Y25.56%
FCF growth 1Y58.39%
FCF growth 3Y63.25%
FCF growth 5Y65.07%
OCF growth 1Y62.48%
OCF growth 3Y54.2%
OCF growth 5Y52.3%

CELLEBRITE DI LTD / CLBT FAQ

What is the fundamental rating for CLBT stock?

ChartMill assigns a fundamental rating of 6 / 10 to CLBT.


Can you provide the valuation status for CELLEBRITE DI LTD?

ChartMill assigns a valuation rating of 3 / 10 to CELLEBRITE DI LTD (CLBT). This can be considered as Overvalued.


What is the profitability of CLBT stock?

CELLEBRITE DI LTD (CLBT) has a profitability rating of 7 / 10.


What are the PE and PB ratios of CELLEBRITE DI LTD (CLBT) stock?

The Price/Earnings (PE) ratio for CELLEBRITE DI LTD (CLBT) is 39.37 and the Price/Book (PB) ratio is 9.89.


Can you provide the financial health for CLBT stock?

The financial health rating of CELLEBRITE DI LTD (CLBT) is 8 / 10.